The presence of glucoside and flavone in BP makes it a nutraceutical agent which has therapeutic efficacy against various diseases such as amnesia, Alzheimers disease, and diabetes (117)
Thus, researchers propose that growth hormone secretagogues like Ipamorelin might elevate fat levels through mechanisms that do not involve growth hormone directly, possibly by enhancing food intake
Another GLP agonist, lixisenatide (which is not approved for obesity), improved motor function in early Parkinsons disease (Meissner WG et al, N Eng J Med 2024;390:11761185)
For more information: www.setriaglutathione.com.
According to recent statistics, approximately 422 million people worldwide are living with diabetes, with obesity being a significant risk factor
It is a selective agonist of ghrelin receptors, meaning it stimulates the release of growth hormone in a manner that closely mimics the natural physiological process